Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last €75.20 EUR
Change Today -4.40 / -5.53%
Volume 0.0
WMD On Other Exchanges
As of 10:23 AM 09/1/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

C. Patrick MacHado

AgeTotal Calculated CompensationThis person is connected to 28 board members in 2 different organizations across 2 different industries.

See Board Relationships
As of Fiscal Year 2014


Mr. C. Patrick Machado, also known as Pat, is a Co-Founder of Medivation, Inc. Mr. Machado served as the Chief Financial Officer, Principal Accounting Officer and Chief Business Officer at Medivation, Inc., until April 18, 2014. He served as an Interim Chief Business and Financial Officer at Medivation, Inc., since November 2013. He served as Chief Financial Officer and Senior Vice President of Orion Acquisition Corp. II since December 17, 2004 and also served as its ...

Read Full Background

Corporate Headquarters*

525 Market Street
San Francisco, California 94105

United States

Phone: 415-543-3470
Fax: 415-543-3411

Board Members Memberships*

Director and Member of Audit Committee


Santa Clara University
Santa Clara University
Harvard Law School

Other Affiliations*

Annual Compensation*

Total Annual Compensation$145,660

Stock Options*

Restricted Stock Awards$174,988
All Other Compensation$6,006
Exercised Options200,000
Exercised Options Value$13,435,060
Exercisable Options436,204
Exercisable Options Value$36,170,598
Unexercisable Options55,146
Unexercisable Options Value$3,206,371
Total Value of Options$52,812,028
Total Number of Options691,350

Total Compensation*

Total Annual Cash Compensation$201,666
Total Short Term Compensation$145,660
Other Long Term Compensation$180,994
Total Calculated Compensation$581,090
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
WMD:GR €75.20 EUR -4.40


Harvey J. Berger M.D.Principal Founder, Chairman, Chief Executive Officer and President
Ariad Pharmaceuticals Inc.
Clay B. Siegall Ph.D.Co-Founder, Chairman, Chief Executive Officer and President
Seattle Genetics, Inc.
Shailesh Ayyangar B.V.Fc & A.H., P.G.D.M.Managing Director, Vice President of South Asia, Global Operations, Executive Director, Member of Audit Committee and Member of Corporate Social Responsibility Committee
Sanofi India Limited
Aijaz Tobaccowalla Managing Director, Director, Member of Board Administrative & Share Transfer Committee, Member of Nomination & Remuneration Committee, Member of Corporate Social Responsibility Committee and Member of Audit Committee
Pfizer Limited
Michael L. Babich Chief Executive Officer, President and Director
INSYS Therapeutics, Inc.
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MEDIVATION INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at